AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31702836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance therapy
Number of subjects: 457
Study 31702836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 30522665 — intervention group
Group type: EXPERIMENTAL
Intervention: Restore DCB
Number of subjects: 240
Study 30522665 — intervention group
Group type: COMPARATOR
Intervention: SeQuent Please DCB
Number of subjects: 240
Study 27345534 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue for fixation of the mesh
Number of subjects: 116
Study 27345534 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene sutures (prolene 2/0) for mesh fixation
Number of subjects: 116
Study 24077960 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention (educational meeting)
Number of subjects: 12
Study 24077960 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended intervention (two group detailing sessions)
Number of subjects: 12
Study 24077960 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 24077960 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention
Number of subjects: 12
Study 24077960 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended intervention
Number of subjects: 12
Study 22048697 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-based sedation management
Number of subjects: 100
Study 22048697 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 20117703 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric Tecnis ZA9003 intraocular lens (IOL)
Number of subjects: 60
Study 20117703 — intervention group
Group type: COMPARATOR
Intervention: Spherical Sensar AR40e intraocular lens (IOL)
Number of subjects: 60
Study 20117703 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 60
Study 17493564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention centers (15 centers)
Number of subjects: 19
Study 17493564 — intervention group
Group type: COMPARATOR
Intervention: Comparison centers (4 centers)
Number of subjects: 19
Study 15901518 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 2- to 3-minute scripted motivational counseling intervention delivered by physicians with an educational brochure and discount helmet coupon
Number of subjects: 200
Study 15901518 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 11931132 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (Fuji II LC)
Number of subjects: 37
Study 11931132 — intervention group
Group type: COMPARATOR
Intervention: Resin composite (Z250/Single Bond)
Number of subjects: 37
Study 11931132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both materials
Number of subjects: 37
Study 10633481 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan-enhanced amino acid drink
Number of subjects: 28
Study 10633481 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan-depleted amino acid drink
Number of subjects: 28
Study 10633481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 10633481 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan-depleted subjects
Number of subjects: 28
Study 10633481 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan-depleted subjects with high scores on Behavioral-Activation-System-Drive
Number of subjects: 28
Study 10633481 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan-depleted subjects scoring high on Buss-Durkee Hostility Inventory Assault and Guilt
Number of subjects: 28
Study 7793215 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 27
Study 7793215 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 27
Study 7793215 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study 1838690 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) infusion (0.04 micrograms/kg/min)
Number of subjects: 32
Study 1838690 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (50 mL of isotonic saline)
Number of subjects: 32
Study 6217950 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g mezlocillin
Number of subjects: 149
Study 6217950 — intervention group
Group type: COMPARATOR
Intervention: 2.0 g ampicillin plus 1.0 g probenecid orally
Number of subjects: 149
Study 6217950 — intervention group
Group type: COMPARATOR
Intervention: 1.8 mega units of procaine penicillin
Number of subjects: 149
Study 30117342 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching intervention in intervention communities
Number of subjects: 14
Study 30117342 — intervention group
Group type: COMPARATOR
Intervention: Comparison communities
Number of subjects: 14
Study 31774955 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 384
Study 31774955 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosphenytoin
Number of subjects: 384
Study 31774955 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 384
Study 28784657 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (2000 IU daily)
Number of subjects: 128
Study 28784657 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 μg daily)
Number of subjects: 128
Study 28784657 — intervention group
Group type: COMPARATOR
Intervention: Cholecalciferol
Number of subjects: 128
Study 28784657 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 128
Study 26393990 — intervention group
Group type: COMPARATOR
Intervention: Musical auditory stimulation in the control group (12 women not taking oral contraceptives)
Number of subjects: 22
Study 26393990 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical auditory stimulation in the oral contraceptive group (10 women taking oral contraceptives)
Number of subjects: 22
Study 24038913 — intervention group
Group type: EXPERIMENTAL
Intervention: <3 years treated with intent to avoid irradiation
Number of subjects: 83
Study 24038913 — intervention group
Group type: COMPARATOR
Intervention: 3-6 years treated with irradiation and chemotherapy
Number of subjects: 83
Study 24038913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study 22561734 — intervention group
Group type: EXPERIMENTAL
Intervention: High lipid meal (LM)
Number of subjects: 18
Study 22561734 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate meal (CM)
Number of subjects: 18
Study 22561734 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein meal (PM)
Number of subjects: 18
Study 20572765 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil‐containing antiseptic (EO)
Number of subjects: 30
Study 20572765 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of azithromycin (AZM)
Number of subjects: 30
Study 20572765 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjunctive treatment)
Number of subjects: 30
Study 18055985 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 45
Study 18055985 — intervention group
Group type: EXPERIMENTAL
Intervention: ASCT
Number of subjects: 45
Study 18055985 — intervention group
Group type: COMPARATOR
Intervention: Induction courses
Number of subjects: 45
Study 18055985 — intervention group
Group type: COMPARATOR
Intervention: HDT
Number of subjects: 45
Study 16053784 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 16
Study 12404692 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.66 g/kg alcohol
Number of subjects: 64
Study 12404692 — intervention group
Group type: EXPERIMENTAL
Intervention: caffeine (110-120 mg)
Number of subjects: 64
Study 12404692 — intervention group
Group type: EXPERIMENTAL
Intervention: both alcohol and caffeine
Number of subjects: 64
Study 12404692 — intervention group
Group type: COMPARATOR
Intervention: neither alcohol nor caffeine (placebo)
Number of subjects: 64
Study 10192973 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily
Number of subjects: 0
Study 10192973 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg once daily
Number of subjects: 0
Study 8669216 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine PCA (2 mg/ml or 3 mg/ml)
Number of subjects: 40
Study 8669216 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine PCA
Number of subjects: 40
Study 2178869 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-l-carnitine (1 g twice daily)
Number of subjects: 36
Study 2178869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 2178869 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-l-carnitine
Number of subjects: 36
Study 6626853 — intervention group
Group type: EXPERIMENTAL
Intervention: imipramine and programmed in‐vivo exposure practice (I+BT)
Number of subjects: 18
Study 6626853 — intervention group
Group type: COMPARATOR
Intervention: imipramine (I)
Number of subjects: 18
Study 31937088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteral catheter removed after 15 days (Group 1)
Number of subjects: 90
Study 31937088 — intervention group
Group type: COMPARATOR
Intervention: Ureteral catheter removed after 30 days (Group 2)
Number of subjects: 90
Study 30839477 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Hip Diaper (prophylactic treatment)
Number of subjects: 90
Study 30839477 — intervention group
Group type: COMPARATOR
Intervention: Observation only (control)
Number of subjects: 90
Study 30839477 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 90
Study 30839477 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Hip Diaper
Number of subjects: 90
Study 30839477 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 90
Study 28802619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2.0 mg/kg at T2 after rocuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine at T2 after rocuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2.0 mg/kg at T2 after vecuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine at T2 after vecuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 4.0 mg/kg at 1–2 PTC after rocuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine at 1–2 PTC after rocuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 4.0 mg/kg at 1–2 PTC after vecuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine at 1–2 PTC after vecuronium
Number of subjects: 1855
Study 28802619 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 16.0 mg/kg at 3 min after rocuronium 1.2 mg/kg
Number of subjects: 1855
Study 26109079 — intervention group
Group type: EXPERIMENTAL
Intervention: Nattokinase (NK) 2,000 FU
Number of subjects: 12
Study 24384878 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator tape (TOT) procedure
Number of subjects: 138
Study 23018466 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous bortezomib 1.3 mg/m²
Number of subjects: 0
Study 23018466 — intervention group
Group type: COMPARATOR
Intervention: Intravenous bortezomib 1.3 mg/m²
Number of subjects: 0
Study 23018466 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous bortezomib 1.3 mg/m² (CAN-1004)
Number of subjects: 0
Study 23018466 — intervention group
Group type: COMPARATOR
Intervention: Intravenous bortezomib 1.3 mg/m² (CAN-1004)
Number of subjects: 0
Study 19686880 — intervention group
Group type: EXPERIMENTAL
Intervention: Short 10-item FMD questionnaire
Number of subjects: 0
Study 19686880 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-item FMD rating scale
Number of subjects: 0
Study 19686880 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic intervention (not specified)
Number of subjects: 0
Study 19686880 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 19839949 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral lumbar paravertebral block (PVB)
Number of subjects: 60
Study 19839949 — intervention group
Group type: COMPARATOR
Intervention: Conventional spinal anaesthesia (SA)
Number of subjects: 60
Study 16314640 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal debulking (≤ 2 cm residual disease)
Number of subjects: 1077
Study 16314640 — intervention group
Group type: COMPARATOR
Intervention: UK patients with no visible residual disease
Number of subjects: 1077
Study 16314640 — intervention group
Group type: COMPARATOR
Intervention: More extensive surgery in non-UK patients
Number of subjects: 1077
Study 12160567 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating adaptation to red and green luminance‐varying gratings of different spatial frequencies
Number of subjects: 0
Study 12160567 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-color adaptation
Number of subjects: 0
Study 12160567 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-selective aftereffect
Number of subjects: 0
Study 12160567 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-insensitive portion of the effect
Number of subjects: 0
Study 9783503 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified CPR (ventilation:compression ratio of 2:15)
Number of subjects: 30
Study 9783503 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR (ventilation:compression ratio of 1:5)
Number of subjects: 30
Study 7945618 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb A1C greater than 6.3%
Number of subjects: 66
Study 7945618 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound markers for fetal macrosomia
Number of subjects: 66
Study 7945618 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal diabetic complications
Number of subjects: 66
Study 7945618 — intervention group
Group type: EXPERIMENTAL
Intervention: Birthweight macrosomia
Number of subjects: 66
Study 3285278 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (2.5 mg/kg/day on days 1 and 2 of each week for 18 months)
Number of subjects: 78
Study 3285278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 31207648 — intervention group
Group type: EXPERIMENTAL
Intervention: SOP implemented weaning process
Number of subjects: 107
Study 31207648 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily echocardiography
Number of subjects: 107
Study 31207648 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulatory support with dobutamine
Number of subjects: 107
Study 31207648 — intervention group
Group type: COMPARATOR
Intervention: Individual decisions weaning process
Number of subjects: 107
Study 28669360 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy via telehealth
Number of subjects: 150
Study 28669360 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure (PE) therapy in person
Number of subjects: 150
Study 27265837 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 2561
Study 24508207 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg twice daily
Number of subjects: 206
Study 24508207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 22481619 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg
Number of subjects: 80
Study 22481619 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-vaginal fenticonazole 600 mg
Number of subjects: 80
Study 20160158 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide 25 mg once daily for 4 days
Number of subjects: 24
Study 17917786 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical surgery
Number of subjects: 32
Study 17917786 — intervention group
Group type: COMPARATOR
Intervention: Conservative surgery
Number of subjects: 32
Study 15950833 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-week behavioral management program
Number of subjects: 116
Study 15950833 — intervention group
Group type: COMPARATOR
Intervention: Usual care for heart failure
Number of subjects: 116
Study 12653794 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide (800 micro g twice daily)
Number of subjects: 13
Study 12653794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 10578211 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (HP; 45% protein, 25% carbohydrates, and 30% fat)
Number of subjects: 13
Study 10578211 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet (HC; 12% protein, 58% carbohydrates, and 30% fat)
Number of subjects: 13
Study 8984701 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone treatment
Number of subjects: 34
Study 8984701 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 34
Study 1816122 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 1 g dose of cefotaxime
Number of subjects: 34
Study 1816122 — intervention group
Group type: COMPARATOR
Intervention: Three doses of cefotaxime
Number of subjects: 34
Study 1816122 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg metronidazole i.v. every 12 h for 72 h
Number of subjects: 34
Study 6859365 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance system
Number of subjects: 0
Study 6859365 — intervention group
Group type: COMPARATOR
Intervention: Passive surveillance system
Number of subjects: 0
Study 29236165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose 1 Curry (D1C)
Number of subjects: 20
Study 29236165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose 2 Curry (D2C)
Number of subjects: 20
Study 29236165 — intervention group
Group type: COMPARATOR
Intervention: Dose 0 Control (D0C)
Number of subjects: 20
Study 29914545 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic totally extraperitoneal (TEP) inguinal repair
Number of subjects: 160
Study 29914545 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 160
Study 26901004 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiration
Number of subjects: 28
Study 26901004 — intervention group
Group type: COMPARATOR
Intervention: Resting expiratory position
Number of subjects: 28
Study 25049315 — intervention group
Group type: EXPERIMENTAL
Intervention: WL‐STE <1 mm
Number of subjects: 763
Study 25049315 — intervention group
Group type: EXPERIMENTAL
Intervention: WL‐STE 1‐2 mm
Number of subjects: 763
Study 25049315 — intervention group
Group type: EXPERIMENTAL
Intervention: WL‐STE >2 mm
Number of subjects: 763
Study 20445204 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-component intervention programs (PHAB + RAVE‐O; PHAB + WIST)
Number of subjects: 279
Study 20445204 — intervention group
Group type: COMPARATOR
Intervention: Control programs (CSS, MATH, phonological control)
Number of subjects: 279
Study 20445204 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-component programs
Number of subjects: 279
Study 20719725 — intervention group
Group type: EXPERIMENTAL
Intervention: Kalangos ring annuloplasty (group 1, 67 patients)
Number of subjects: 129
Study 20719725 — intervention group
Group type: COMPARATOR
Intervention: De Vega semicircular annuloplasty (group 2, 62 patients)
Number of subjects: 129
Study 17385190 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy (SEGT) plus three classes of relaxation therapy
Number of subjects: 227
Study 17385190 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving three classes of relaxation therapy
Number of subjects: 227
Study 16350553 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 ml@4ml/s
Number of subjects: 45
Study 16350553 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 ml = 60 ml@5ml/s + 80 ml@3ml/s
Number of subjects: 45
Study 16350553 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml@4ml/s
Number of subjects: 45
Study 11408506 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC (vincristine, dactinomycin, cyclophosphamide), n = 235
Number of subjects: 883
Study 11408506 — intervention group
Group type: EXPERIMENTAL
Intervention: VAI (vincristine, dactinomycin, ifosfamide), n = 222
Number of subjects: 883
Study 11408506 — intervention group
Group type: EXPERIMENTAL
Intervention: VIE (vincristine, ifosfamide, etoposide), n = 236
Number of subjects: 883
Study 11408506 — intervention group
Group type: COMPARATOR
Intervention: HF-RT (hyperfractionated radiotherapy)
Number of subjects: 883
Study 11408506 — intervention group
Group type: COMPARATOR
Intervention: C-RT (conventional radiotherapy)
Number of subjects: 883
Study 11408506 — intervention group
Group type: EXPERIMENTAL
Intervention: VA chemotherapy
Number of subjects: 883
Study 11408506 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized patient subsets
Number of subjects: 883
Study 11408506 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 10 years with paratesticular primaries
Number of subjects: 883
Study 9723149 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of referral strategies (fixed appointment, involvement of the family, presence of the aftercare person, motivational counselling)
Number of subjects: 0
Study 7994812 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapidil 100 mg TID
Number of subjects: 254
Study 7994812 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg TID
Number of subjects: 254
Study 2657296 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline with epinephrine (1:200,000)
Number of subjects: 42
Study 2657296 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with epinephrine (1:200,000)
Number of subjects: 42
Study 2657296 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 42
Study 2657296 — intervention group
Group type: COMPARATOR
Intervention: Control group (no infiltration)
Number of subjects: 42
Study 31693545 — intervention group
Group type: EXPERIMENTAL
Intervention: Offset analgesia (OA) response in patients with migraine
Number of subjects: 26
Study 31693545 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26
Study 31022555 — intervention group
Group type: EXPERIMENTAL
Intervention: Literacy-adapted group cognitive-behavioral therapy (CBT)
Number of subjects: 241
Study 31022555 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain psychoeducation groups (EDU)
Number of subjects: 241